In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Pulmonary hypertension: future expectations and annual G6 meeting 2012

Add to calendar19/10/20120:00 20/10/20120:00 Europe/Paris Pulmonary hypertension: future expectations and annual G6 meeting 2012 European Society of Cardiology contact@escardio.org true DD/MM/YYYY
In-person
event


Course Objectives

The objectives of the course include the discussion of the gaps of knowledge, of evidence and of organization in the field of pulmonary arterial hypertension. The stakeholders roundtable facilitates the promotion of proposals for the future.  

Target Audience

Cardiologists, pediatric cardiologists, pulmonologists, internal medicine, rheumatologists, registered nurses.             

Course Directors

N. Galiè (IT), G. Simonneau (FR)

Faculty

D. Badesch (USA), M.Beghetti (CH), A. El-Gazayerly (NL), G.Fischer (AT), A.Ghofrani (DE), S. Gibbs (UK), W. Gin-Sing (UK), D. Ivy (USA), N.Kim (USA), J. Newman (USA), W.Seeger (DE), O. Sitbon (FR), A. Torbicki (PL), R.Tuder (USA), JL Vachiery (BE), A.Vonk Noordegraaf (NL)

Programme

Friday 19 October

Session 1:  N. Galiè - G. Simonneau

08:50 - 09:00         Welcome and Introduction - G. Simonneau
09:00 - 09:30         Pathology – R. Tuder
09:30 - 10:00         Pathobiology – R. Tuder
10:00 - 10:30         Genetics/Genomics – J. Newman

11:00 - 11: 30       Definitions and Classifications - 
G. Simonneau
11:30 - 12:00        Pathophysiology - A.Vonk Nordegraaf 
 
Session 2:  S. Gibbs, O. Sitbon

13:00 – 13:30  Epidemiology and registries – O. Sitbon
13:30 – 14:00  Diagnosis and Prognosis – D. Badesch
14:00 – 14:30  Therapy – Standard of care - N. Galiè
14:30 – 15:00  Discussion

Session 3  JL. Vachiery, M. Beghetti

15:30 – 16:00  Therapy – Goals - O. Sitbon
16:00 – 16:30  New Design and New Therapies – A. Ghofrani
16:30 – 17:00  CTEPH – N Kim
17:00 – 17:30  PH due to Left Heart Disease and Chronic Lung Disease – W. Seeger
17:30 – 18:00  Pediatric PH – D. Ivy

Saturday 20 October

Session 4 – G 6 Meeting: A Torbicki, G. Fischer

09:00 – 09:30    Expectations from Patients – G. Fischer
09:30 – 10:00    Expectation from Nurses – W. Gin-Sing 

10:30 – 11:00     The expectations of the Regulatory Agencies
A. El Gazayerly
11:00 – 11:30     The expectations of the Industry – 
M. Ianosev
11:30 – 12:00     The expectations of healthcare providers -
D. Ivy 

Session 5:  N. Galiè - G. Simonneau

12:00–12:45 Roundtable discussion with invited         representatives of healthcare providers and industry (M. Alison (Bayer), L. Varanese (Eli-Lilly), M. Ianosev (GSK), S. Teal (Pfizer), A.Maresta (Actelion), A. El Gazayerly
   
12:45 – 13:00    Summary of the meeting and perspectives 
N. Galiè